Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces that it has signed a subscription agreement (the "Agreement") and completed the exchange of 5,247,493 convertible preference ...
Summary Global Markets Direct's, 'Hutchison MediPharma Ltd - Product Pipeline Review - 2016', provides an overview of the Hutchison MediPharma Ltd's pharmaceutical research and development focus. The ...
Eli Lilly & Company has entered into a licensing, co-development and commercialisation agreement in China with Hutchinson MediPharma Limited (HMP) for its investigational cancer drug, fruquintinib.
Hong Kong-based Hutchison China MediTech has cemented its already majority stake in Hutchison MediPharma via a share exchange deal with Japan's Mitsui & Co. in a disclosure notice with few details, ...
Hutchison MediPharma Limited (HMP), an R&D company majority owned by Chi-Med, has entered into a licensing, co-development, and commercialization agreement with Eli Lilly and Company in China for ...
Discover the address of Medipharma in Jodhpur, Rajasthan. Access complete location details, get directions via our interactive map. If you manage ‘Medipharma’ in Jodhpur and wish to update your ...
No articles found. AccuTarget MediPharma (Shanghai) Co., Ltd did not contribute to any primary research papers from Nature Index journals in the current 12 month window.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results